1
Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
Condition(s): Hypertension Last Updated: May 9, 2013Recruiting
229 Clinical Trials for: Valsartan, Page 1 of 12
Hide Studies Not Seeking New Volunteers
2
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
Condition(s): Hypertension; High Blood Pressure Last Updated: September 13, 2011Completed
3
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
Condition(s): Essential Hypertension Last Updated: May 18, 2011Completed
4
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Condition(s): Hypertension Last Updated: December 3, 2012Completed
5
Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan
Condition(s): Hypertension; Hyperlipidemia Last Updated: May 31, 2012Completed
6
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
Condition(s): Hypertension Last Updated: April 15, 2011Completed
7
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
Condition(s): Hypertension Last Updated: April 26, 2011Completed
8
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
Condition(s): Stage 2 Hypertension Last Updated: March 31, 2011Completed
9
Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
Condition(s): Hypertension Last Updated: June 15, 2012Completed
10
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Condition(s): Hypertension Last Updated: May 4, 2011Completed
11
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Condition(s): Diabetes Mellitus, Type 2 Last Updated: June 27, 2011Completed
12
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Condition(s): Proteinuric Kidney Disease; Diabetic Nephropathy; Hypertensive Nephrosclerosis; IgA Nephropathy; Focal Segmental Glomerulosclerosis; Glomerulopathy (Obesity-associated); Glomerulonephritis, Membranous Last Updated: April 6, 2012Active, not recruiting
13
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
Condition(s): Chronic Kidney Disease; Hypertension Last Updated: March 20, 2009Completed
14
Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study
Condition(s): Hypertension Last Updated: April 17, 2013Recruiting
15
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers
Condition(s): Healthy; Pharmacokinetics of Valsartan Last Updated: May 26, 2010Completed
16
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
Condition(s): Healthy Last Updated: June 21, 2007Completed
17
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
Condition(s): Hypertension Last Updated: June 30, 2010Completed
18
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
Condition(s): Hypertension Last Updated: May 6, 2012Completed
19
Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension
Condition(s): Salt-sensitive Hypertension Last Updated: April 2, 2013Recruiting
20
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)
Condition(s): Healthy Normotensive Participants Last Updated: January 10, 2013Completed
